Total Payments
$3,270
2024 Payments
$1,468
Companies
30
Transactions
196
Medicare Patients
3,360
Medicare Billing
$367,433
Payment Breakdown by Category
Food & Beverage$3,207 (98.1%)
Education$63.71 (1.9%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,207 | 190 | 98.1% |
| Education | $63.71 | 6 | 1.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $572.41 | 22 | $0 (2024) |
| ABBVIE INC. | $332.67 | 26 | $0 (2024) |
| Novo Nordisk Inc | $319.45 | 21 | $0 (2024) |
| GlaxoSmithKline, LLC. | $249.84 | 20 | $0 (2024) |
| Medtronic Vascular, Inc. | $213.86 | 2 | $0 (2017) |
| Astellas Pharma US Inc | $176.13 | 11 | $0 (2024) |
| PFIZER INC. | $151.19 | 8 | $0 (2024) |
| Lilly USA, LLC | $148.16 | 9 | $0 (2024) |
| Merck Sharp & Dohme LLC | $145.69 | 11 | $0 (2024) |
| Daiichi Sankyo Inc. | $121.49 | 12 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,468 | 83 | AstraZeneca Pharmaceuticals LP ($464.82) |
| 2023 | $380.30 | 24 | AbbVie Inc. ($73.19) |
| 2022 | $343.37 | 23 | Novo Nordisk Inc ($102.15) |
| 2019 | $23.80 | 2 | EISAI INC. ($23.80) |
| 2018 | $35.57 | 3 | AstraZeneca Pharmaceuticals LP ($12.32) |
| 2017 | $1,019 | 61 | Medtronic Vascular, Inc. ($213.86) |
All Payment Transactions
196 individual payment records from CMS Open Payments — Page 1 of 8
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | Merck Sharp & Dohme LLC | LAGEVRIO (Drug) | Food and Beverage | In-kind items and services | $20.51 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 12/17/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $14.66 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 12/05/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $18.35 | General |
| Category: Diabetes | ||||||
| 12/05/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $9.97 | General |
| Category: NEUROSCIENCE | ||||||
| 11/28/2024 | Regeneron Healthcare Solutions, Inc. | EVKEEZA (Biological) | Food and Beverage | In-kind items and services | $17.97 | General |
| Category: CARDIOVASCULAR AND METABOLISM | ||||||
| 11/20/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $14.53 | General |
| Category: Respiratory | ||||||
| 11/19/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug), TRELEGY ELLIPTA | Food and Beverage | In-kind items and services | $9.83 | General |
| Category: RESPIRATORY | ||||||
| 10/25/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $1.61 | General |
| Category: NEUROSCIENCE | ||||||
| 10/21/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $3.19 | General |
| Category: NEUROSCIENCE | ||||||
| 10/17/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $18.21 | General |
| Category: Oncology | ||||||
| 10/16/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $17.30 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/09/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $17.76 | General |
| Category: Diabetes | ||||||
| 10/09/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug), TRELEGY ELLIPTA | Food and Beverage | In-kind items and services | $11.84 | General |
| Category: RESPIRATORY | ||||||
| 10/07/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $4.17 | General |
| Category: NEUROSCIENCE | ||||||
| 10/03/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $18.76 | General |
| Category: Respiratory | ||||||
| 10/03/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $15.64 | General |
| Category: Biological | ||||||
| 09/28/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $18.46 | General |
| Category: NEUROSCIENCE | ||||||
| 09/26/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $23.83 | General |
| Category: Diabetes Care | ||||||
| 09/25/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $17.99 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/18/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $16.00 | General |
| Category: RESPIRATORY | ||||||
| 09/12/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $12.98 | General |
| Category: NEUROSCIENCE | ||||||
| 09/05/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $20.49 | General |
| Category: Diabetes | ||||||
| 09/05/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $18.97 | General |
| Category: NEUROSCIENCE | ||||||
| 09/03/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $23.17 | General |
| Category: PAIN | ||||||
| 08/29/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $15.70 | General |
| Category: Biological | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 11 | 844 | 1,198 | $295,037 | $106,974 |
| 2022 | 13 | 748 | 1,184 | $253,359 | $95,457 |
| 2021 | 13 | 874 | 1,304 | $189,746 | $72,016 |
| 2020 | 17 | 894 | 1,372 | $184,598 | $92,987 |
Total Patients
3,360
Total Services
5,058
Medicare Billing
$367,433
Procedure Codes
54
All Medicare Procedures & Services
54 procedure records from CMS Medicare Utilization — Page 2 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 133 | 164 | $19,680 | $8,072 | 41.0% |
| 90732 | Vaccine for pneumococcal polysaccharide for injection beneath the skin or into muscle, patient 2 years or older | Office | 2021 | 56 | 56 | $7,840 | $6,878 | 87.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 76 | 76 | $13,946 | $4,742 | 34.0% |
| 90662 | Vaccine for influenza for injection into muscle, split virus, preservation free | Office | 2021 | 72 | 72 | $5,040 | $4,677 | 92.8% |
| 90670 | Pneumococcal vaccine for injection into muscle | Office | 2021 | 11 | 11 | $2,750 | $2,644 | 96.1% |
| 99496 | Transitional care management services, highly complexity, requiring face-to-face visits within 7 days of discharge | Office | 2021 | 18 | 20 | $7,480 | $1,715 | 22.9% |
| G0008 | Administration of influenza virus vaccine | Office | 2021 | 82 | 83 | $3,320 | $1,561 | 47.0% |
| G0009 | Administration of pneumococcal vaccine | Office | 2021 | 67 | 67 | $2,680 | $1,240 | 46.3% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 14 | 15 | $3,525 | $1,106 | 31.4% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Office | 2021 | 20 | 20 | $1,400 | $836.92 | 59.8% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 11 | 11 | $1,925 | $817.87 | 42.5% |
| 93000 | Routine ekg using at least 12 leads including interpretation and report | Office | 2021 | 26 | 27 | $810.00 | $266.60 | 32.9% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 287 | 638 | $111,650 | $51,154 | 45.8% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2020 | 60 | 60 | $11,010 | $7,573 | 68.8% |
| 90670 | Pneumococcal vaccine for injection into muscle | Office | 2020 | 26 | 26 | $6,500 | $5,825 | 89.6% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Office | 2020 | 46 | 53 | $12,455 | $5,691 | 45.7% |
| 90662 | Vaccine for influenza for injection into muscle | Office | 2020 | 80 | 83 | $5,978 | $5,031 | 84.2% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 81 | 92 | $11,040 | $4,882 | 44.2% |
| 99496 | Transitional care management services, highly complexity, requiring face-to-face visits within 7 days of discharge | Office | 2020 | 15 | 15 | $5,610 | $3,018 | 53.8% |
| 99495 | Transitional care management services, moderately complexity, requiring face-to-face visits within 14 days of discharge | Office | 2020 | 11 | 11 | $2,915 | $1,806 | 61.9% |
| G0008 | Administration of influenza virus vaccine | Office | 2020 | 92 | 96 | $3,920 | $1,759 | 44.9% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 14 | 14 | $3,710 | $1,259 | 33.9% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2020 | 20 | 21 | $2,025 | $1,161 | 57.3% |
| 99441 | Physician telephone patient service, 5-10 minutes of medical discussion | Office | 2020 | 27 | 29 | $1,625 | $1,080 | 66.5% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Office | 2020 | 13 | 13 | $1,490 | $1,048 | 70.4% |
About Dr. Richard Shaw, D.O
Dr. Richard Shaw, D.O is a Internal Medicine healthcare provider based in Woodbury, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/30/2007. The National Provider Identifier (NPI) number assigned to this provider is 1467646604.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Richard Shaw, D.O has received a total of $3,270 in payments from pharmaceutical and medical device companies, with $1,468 received in 2024. These payments were reported across 196 transactions from 30 companies. The most common payment nature is "Food and Beverage" ($3,207).
As a Medicare-enrolled provider, Shaw has provided services to 3,360 Medicare beneficiaries, totaling 5,058 services with total Medicare billing of $367,433. Data is available for 4 years (2020–2023), covering 54 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Location Woodbury, NJ
- Active Since 08/30/2007
- Last Updated 03/02/2018
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1467646604
Products in Payments
- AIRSUPRA (Drug) $222.24
- Resolute (Device) $213.86
- BREZTRI (Drug) $196.15
- Ozempic (Drug) $164.67
- QULIPTA (Drug) $154.38
- TRELEGY ELLIPTA (Drug) $122.56
- Movantik (Drug) $120.73
- FARXIGA (Drug) $115.48
- Rybelsus (Drug) $111.38
- Veozah (Drug) $109.92
- MOUNJARO (Drug) $100.63
- NURTEC ODT (Drug) $100.47
- VRAYLAR (Drug) $99.68
- Cologuard Collection Kit (Device) $89.60
- JANUVIA (Drug) $77.97
- Myrbetriq (Drug) $66.21
- Otezla (Drug) $61.93
- UBRELVY (Drug) $61.83
- JARDIANCE (Drug) $59.49
- AREXVY (Drug) $58.54
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Woodbury
Dr. Karen Schwartz, M.d, M.D
Internal Medicine — Payments: $393,480
Internal Medicine $393,480
Irina Murakhovskaya, M.d, M.D
Internal Medicine — Payments: $189,283
Internal Medicine $189,283
Bernard Quebral, Md, MD
Internal Medicine — Payments: $46,880
Internal Medicine $46,880
Anthony Bonett, Md, MD
Internal Medicine — Payments: $12,608
Internal Medicine $12,608
Dr. Linda Aquilino, D.o, D.O
Internal Medicine — Payments: $11,480
Internal Medicine $11,480
David Gehring, Md, MD
Internal Medicine — Payments: $3,934
Internal Medicine $3,934